156 related articles for article (PubMed ID: 31134151)
1. Long Non-coding RNA CASC2 Enhances the Antitumor Activity of Cisplatin Through Suppressing the Akt Pathway by Inhibition of miR-181a in Esophageal Squamous Cell Carcinoma Cells.
Zhu D; Yu Y; Qi Y; Wu K; Liu D; Yang Y; Zhang C; Zhao S
Front Oncol; 2019; 9():350. PubMed ID: 31134151
[No Abstract] [Full Text] [Related]
2. Long non-coding RNA CASC2 enhanced cisplatin-induced viability inhibition of non-small cell lung cancer cells by regulating the PTEN/PI3K/Akt pathway through down-regulation of miR-18a and miR-21.
Li L; Zhang H; Wang X; Wang J; Wei H
RSC Adv; 2018 Apr; 8(29):15923-15932. PubMed ID: 35542225
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA CASC2 inhibits tumorigenesis via the miR-181a/PLXNC1 axis in melanoma.
Wang Z; Wang X; Zhou H; Dan X; Jiang L; Wu Y
Acta Biochim Biophys Sin (Shanghai); 2018 Mar; 50(3):263-272. PubMed ID: 29514220
[TBL] [Abstract][Full Text] [Related]
4. LncRNA CASC2 Interacts With miR-181a to Modulate Glioma Growth and Resistance to TMZ Through PTEN Pathway.
Liao Y; Shen L; Zhao H; Liu Q; Fu J; Guo Y; Peng R; Cheng L
J Cell Biochem; 2017 Jul; 118(7):1889-1899. PubMed ID: 28121023
[TBL] [Abstract][Full Text] [Related]
5. ALC1 knockdown enhances cisplatin cytotoxicity of esophageal squamous cell carcinoma cells by inhibition of glycolysis through PI3K/Akt pathway.
Li F; Zhang Z; Wang P; Wen P; Xu Q; Wang Y; Pan P; Ma L
Life Sci; 2019 Sep; 232():116679. PubMed ID: 31340168
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA CASC2 suppresses esophageal squamous cell carcinoma progression by increasing SOCS1 expression.
Sun K; Zhang G
Cell Biosci; 2019; 9():90. PubMed ID: 31728180
[TBL] [Abstract][Full Text] [Related]
7. RNPC1 inhibits non-small cell lung cancer progression via regulating miR-181a/CASC2 axis.
Yang L; Zhang Y; Ling C; Heng W
Biotechnol Lett; 2018 Mar; 40(3):543-550. PubMed ID: 29288351
[TBL] [Abstract][Full Text] [Related]
8. miRNA-181a-5p Enhances the Sensitivity of Cells to Cisplatin in Esophageal Adenocarcinoma by Targeting CBLB.
Yang S; Wang P; Wang S; Cong A; Zhang Q; Shen W; Li X; Zhang W; Han G
Cancer Manag Res; 2020; 12():4981-4990. PubMed ID: 32612385
[TBL] [Abstract][Full Text] [Related]
9. miR-145 sensitizes esophageal squamous cell carcinoma to cisplatin through directly inhibiting PI3K/AKT signaling pathway.
Zheng TL; Li DP; He ZF; Zhao S
Cancer Cell Int; 2019; 19():250. PubMed ID: 31582906
[TBL] [Abstract][Full Text] [Related]
10. ELF1 activated long non-coding RNA CASC2 inhibits cisplatin resistance of non-small cell lung cancer via the miR-18a/IRF-2 signaling pathway.
Xiao XH; He SY
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3130-3142. PubMed ID: 32271431
[TBL] [Abstract][Full Text] [Related]
11. LncRNA-TUSC7/miR-224 affected chemotherapy resistance of esophageal squamous cell carcinoma by competitively regulating DESC1.
Chang ZW; Jia YX; Zhang WJ; Song LJ; Gao M; Li MJ; Zhao RH; Li J; Zhong YL; Sun QZ; Qin YR
J Exp Clin Cancer Res; 2018 Mar; 37(1):56. PubMed ID: 29530057
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of lncRNA CASC2 facilitates osteosarcoma growth and invasion through miR-181a.
Ba Z; Gu L; Hao S; Wang X; Cheng Z; Nie G
Cell Prolif; 2018 Feb; 51(1):. PubMed ID: 29194827
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA CASC2 enhances cisplatin sensitivity in oral squamous cell cancer cells by the miR-31-5p/KANK1 axis.
Wang J; Jia J; Zhou L
Neoplasma; 2020 Nov; 67(6):1279-1292. PubMed ID: 32787433
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-181a enhances the chemoresistance of human cervical squamous cell carcinoma to cisplatin by targeting PRKCD.
Chen Y; Ke G; Han D; Liang S; Yang G; Wu X
Exp Cell Res; 2014 Jan; 320(1):12-20. PubMed ID: 24183997
[TBL] [Abstract][Full Text] [Related]
15. The Long Non-Coding RNA CASC2 Suppresses Cell Viability, Migration, and Invasion in Hepatocellular Carcinoma Cells by Directly Downregulating miR-183.
Sun J; Liu L; Zou H; Yu W
Yonsei Med J; 2019 Oct; 60(10):905-913. PubMed ID: 31538425
[TBL] [Abstract][Full Text] [Related]
16. Aberrant expression of LncRNA CASC2 mediated the cell viability, apoptosis and autophagy of colon cancer cells by sponging miR-19a via NF-κB signaling pathway.
Zhang P; Pan Y; Sun J; Pan G
Int J Exp Pathol; 2021 Jun; 102(3):163-171. PubMed ID: 33983643
[TBL] [Abstract][Full Text] [Related]
17. LncRNA NRON negatively regulates cisplatin-induced cell apoptosis via downregulating miR-31 in esophageal squamous cell carcinomas.
Liu B; Li X; Xie J; Feng Z; Lin N; Yu M
In Vitro Cell Dev Biol Anim; 2022 Jan; 58(1):37-43. PubMed ID: 35075603
[TBL] [Abstract][Full Text] [Related]
18. LncRNA CASC2 inhibited the viability and induced the apoptosis of hepatocellular carcinoma cells through regulating miR-24-3p.
Fan JC; Zeng F; Le YG; Xin L
J Cell Biochem; 2018 Aug; 119(8):6391-6397. PubMed ID: 29091305
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-181a-5p prevents the progression of esophageal squamous cell carcinoma
Wang M; Huang C; Gao W; Zhu Y; Zhang F; Li Z; Tian Z
Aging (Albany NY); 2022 Apr; 14(8):3540-3553. PubMed ID: 35468097
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA cancer susceptibility candidate 2 regulates the function of human fibroblast-like synoviocytes via the microRNA-18a-5p/B-cell translocation gene 3 signaling axis in rheumatoid arthritis.
Ye Z; Wei L; Yin X; Li H; Qin G; Li S; Peng T; Liu B; Zhao S; Zhuo Q
Bioengineered; 2022 Feb; 13(2):3240-3250. PubMed ID: 35045800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]